Search - tctmd.com

Displaying 401 - 420 of 1104

Sort: Relevancy | Date

Presentation

Impact of Proton Pump Inhibitors (PPIs) on GI Bleeding Associated With Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) in Post-MI Patients Taking Antithrombotics

Presenter: Schjerning Olsen

October 28, 2015

News Daily News

没有钱就得不到药物：全球范围内心血管疾病二级预防的障碍

Caitlin E. Cox

October 27, 2015

News Daily News

Sin Dinero Ni Medicamentos: Barreras Globales a la Prevención Secundaria de la Enfermedad Cardiovascular

Caitlin E. Cox

October 27, 2015

News Daily News

No Money, No Drugs: Global Barriers to Secondary CVD Prevention

Caitlin E. Cox

October 27, 2015

Presentation

Availability and Affordability of Cardiovascular Disease Medicines and Their Effect on Use in High-, Middle-, and Low-Income Countries

Presenter: R. Khatib

October 26, 2015

News Industry News

FDA approves Praxbind, the first reversal agent for the anticoagulant Pradaxa

October 20, 2015

Presentation TCT 2015

Neurological Complications of TEVAR: Prevention and Management

Presenter: Wilson Y. Szeto, Rodney White, Michael D. Dake

October 15, 2015

Presentation TCT 2015

Debate: Are We Really Ready for Phase III Trials? Yes, Mesenchymal Cells Are Ready to Be Tested for Prevention and Treatment of Chronic Ischemic and Nonischemic Heart Failure!

Presenter: Francisco Fdez-Aviles, Timothy D. Henry, Emerson C. Perin

October 15, 2015

Presentation TCT 2015

Vorapaxar: Lessons From the Randomized Trials in ACS and for Secondary Prevention

Presenter: Eric R. Bates, Neal S. Kleiman, Ori Ben-Yehuda

October 15, 2015

Presentation TCT 2015

Convince Me in 5 Minutes or Less That: Intravenous and Not Oral Hydration Is the Cornerstone for Contrast Nephropathy Prevention!

Presenter: Somjot S. Brar, Richard Solomon

October 15, 2015

News Industry News

Long-Term Study Results Show That PFO Closure May Be Effective In Preventing Recurrent Cryptogenic Stroke, Particularly In Younger Patients

October 15, 2015

Presentation TCT 2015

The Critical Role of Lesion Preparation for BRS: Effects of Plaque Morphology, Components, and Novel Devices

Presenter: Detlef G. Mathey, Nicolas M. Van Mieghem, Giulio Guagliumi

October 14, 2015

Presentation TCT 2015

Scaffold Expansion as the Essential Requirement to Prevent BRS Failure

Presenter: Detlef G. Mathey, Nicolas M. Van Mieghem, Stephan Achenbach

October 14, 2015

Presentation TCT 2015

Tips and Tricks to Optimize Acute and Long-term BRS Outcomes

Presenter: Detlef G. Mathey, Nicolas M. Van Mieghem, Antonio Colombo

October 14, 2015

Presentation TCT 2015

Imaging Insights Into BRS Failure Modes (Thrombosis and Restenosis)

Presenter: Detlef G. Mathey, Nicolas M. Van Mieghem, Yoshinobu Onuma

October 14, 2015

Presentation TCT 2015

Neoatherosclerosis After BRS May Occur

Presenter: Detlef G. Mathey, Nicolas M. Van Mieghem, Corrado Tamburino

October 14, 2015

Presentation TCT 2015

Incidence and Predictors of BRS Scaffold Thrombosis

Presenter: Detlef G. Mathey, Nicolas M. Van Mieghem, Luis Ortega Paz, MD

October 14, 2015

Presentation TCT 2015

What Are the Hard Data Regarding the Impact of Medical Therapy on Stroke Prevention in Established Severe Carotid Stenosis?

Presenter: William A. Gray, D. Christopher Metzger, Klaus D. Mathias

October 14, 2015

News Conference News TCT 2015

CREST-2 Triggers Spirited Debate on Merits of CAS vs. CEA

Todd Neale

October 14, 2015

Presentation TCT 2015

TCT 73: Impact of Routine MicroNet-Covered Embolic Prevention Stent System Use on Contemporary Carotid Revascularization All-Comer PARADIGM Study

Presenter: Mark C. Bates, Mark H. Wholey, Piotr Musialek

October 13, 2015

Advertisement

Impact of Proton Pump Inhibitors (PPIs) on GI Bleeding Associated With Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) in Post-MI Patients Taking Antithrombotics

没有钱就得不到药物：全球范围内心血管疾病二级预防的障碍

Sin Dinero Ni Medicamentos: Barreras Globales a la Prevención Secundaria de la Enfermedad Cardiovascular

No Money, No Drugs: Global Barriers to Secondary CVD Prevention

Availability and Affordability of Cardiovascular Disease Medicines and Their Effect on Use in High-, Middle-, and Low-Income Countries

FDA approves Praxbind, the first reversal agent for the anticoagulant Pradaxa

Neurological Complications of TEVAR: Prevention and Management

Debate: Are We Really Ready for Phase III Trials? Yes, Mesenchymal Cells Are Ready to Be Tested for Prevention and Treatment of Chronic Ischemic and Nonischemic Heart Failure!

Vorapaxar: Lessons From the Randomized Trials in ACS and for Secondary Prevention

Convince Me in 5 Minutes or Less That: Intravenous and Not Oral Hydration Is the Cornerstone for Contrast Nephropathy Prevention!

Long-Term Study Results Show That PFO Closure May Be Effective In Preventing Recurrent Cryptogenic Stroke, Particularly In Younger Patients

The Critical Role of Lesion Preparation for BRS: Effects of Plaque Morphology, Components, and Novel Devices

Scaffold Expansion as the Essential Requirement to Prevent BRS Failure

Tips and Tricks to Optimize Acute and Long-term BRS Outcomes

Imaging Insights Into BRS Failure Modes (Thrombosis and Restenosis)

Neoatherosclerosis After BRS May Occur

Incidence and Predictors of BRS Scaffold Thrombosis

What Are the Hard Data Regarding the Impact of Medical Therapy on Stroke Prevention in Established Severe Carotid Stenosis?

CREST-2 Triggers Spirited Debate on Merits of CAS vs. CEA

TCT 73: Impact of Routine MicroNet-Covered Embolic Prevention Stent System Use on Contemporary Carotid Revascularization All-Comer PARADIGM Study

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content